Heart Valve Disease Clinical Trial
Official title:
The Effects of Levosimendan on Haemodynamics in Patients Undergoing Elective Aortic Valve Replacement (AVR)Together With Coronary Artery Bypass Grafting
Patients undergoing aortic valve replacement (AVR) surgery with coronary artery bypass
grafting (CABG) are at risk of left ventricular dysfunction. The aim of the study is to
describe the haemodynamic effects of levosimendan in comparison to placebo in patients
undergoing elective aortic valve replacement (AVR) together with coronary artery bypass
grafting (CABG) surgery. The study is randomized, double-blinded, placebo-controlled and
will be carried out in Heart Center.
Twenty four patients will be randomized into two groups of 12. The treatment group will
receive 24 hour infusion of levosimendan preoperatively where as the placebo group will
receive an identical infusion of thiamine coloured glucose. The splanchnic perfusion will be
measured by the means of vena hepatica cannulation. CircMon B202 (JR Medical Ltd, Tallinn,
Estonia) is used for the measurement of whole-body impedance cardiography derived heart
rate, cardiac index, left cardiac work index, systemic vascular resistance index (SVRI), and
extracellular water (ECW). Surgical procedure, anaesthesia and cardio protection will be
carried out as in standard care. Echo cardiography will be done pre- and postoperatively.
Haemodynamics will be recorded hourly and mixed venous saturation every fourth hour for 24
hours.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT02527629 -
Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the "Surveillance")
|
||
| Completed |
NCT01426776 -
Effect of Heart Valve Replacement on Cheyne-Stokes Respiration
|
N/A | |
| Completed |
NCT01178710 -
Effect of Simvastatin on Cardiac Function
|
N/A | |
| Completed |
NCT00581399 -
A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery
|
Phase 2 | |
| Withdrawn |
NCT00187304 -
ACTION - Anticoagulation Treatment Influence on Post-operative Patients
|
Phase 4 | |
| Terminated |
NCT00700947 -
Using Beta Blockers to Treat Mitral Regurgitation
|
Phase 1 | |
| Recruiting |
NCT02650388 -
Frailty and Cognitive Function Assessment of TAVI Patients
|
Phase 4 | |
| Recruiting |
NCT02574650 -
Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.
|
N/A | |
| Completed |
NCT01996657 -
D-dimer and Oral Anticoagulation Therapy in Patients With Mechanical Valve Replacement
|
N/A | |
| Terminated |
NCT00598936 -
A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients
|
Phase 1 | |
| Terminated |
NCT01812174 -
On-X Heart Valve - 17mm Aortic and 23mm Mitral
|
N/A | |
| Recruiting |
NCT03225612 -
Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
|
N/A | |
| Completed |
NCT01384643 -
Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery
|
Phase 4 | |
| Completed |
NCT01558765 -
CopenHeartVR - Integrated Rehabilitation of Patients After Heart Valve Surgery
|
Phase 2 | |
| Active, not recruiting |
NCT00291525 -
Randomized On-X Anticoagulation Trial
|
N/A | |
| Completed |
NCT02867930 -
Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Patients Undergoing Trans-esophageal Echocardiography
|
Phase 4 | |
| Recruiting |
NCT02478008 -
A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)
|
N/A | |
| Completed |
NCT02790008 -
Magnetic Resonance Imaging and Fibrosis
|
||
| Completed |
NCT02587039 -
An Intervention to Reduce Delirium After Cardiac Surgery
|
N/A |